Related references
Note: Only part of the references are listed.Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
Lenneke Minjon et al.
BMJ OPEN (2022)
Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database
Kangyuan Guo et al.
FRONTIERS IN PHARMACOLOGY (2022)
Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea
Soo Min Jeon et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2021)
Trends in Antipsychotic Medication Use in Young Privately Insured Children
Greta A. Bushnell et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2021)
Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
Heidi Taipale et al.
SCHIZOPHRENIA BULLETIN (2021)
Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Metabolique a Long Terme des Jeunes Traites par Antipsychotiques de Deuxieme Generation, Cinq ans Apres la publication des Lignes Directrices Camesa: Faisons-Nous des Progres?
Sarra Jazi et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)
Second-Generation Antipsychotic Drugs for Children and Adolescents
Yuichi Onishi et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2021)
Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea
Soo Min Jeon et al.
FRONTIERS IN PSYCHIATRY (2021)
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Mariken Dinnissen et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2020)
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects
Marco Solmi et al.
WORLD PSYCHIATRY (2020)
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
Concetta Rafaniello et al.
FRONTIERS IN PSYCHIATRY (2020)
'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'
Florentia Kaguelidou et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2020)
Incidence of adverse events in antipsychotic-naive children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE)
Marie-Line Menard et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
Anne Benard-Laribiere et al.
THERAPIE (2019)
Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
Marc Krause et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Suicide Risk and Mental Disorders
Louise Bradvik
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics
Esther S. Lee et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2018)
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Oskar Halfdanarson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole
Klaus Damgaard Jakobsen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis
Andrea Cipriani et al.
LANCET (2016)
Incidence of adverse events in antipsychotic-naive children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE)
Marie-Line Menard et al.
BMJ OPEN (2016)
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Maurizio Pompili et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
Goji Kimura et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
GUIDELINES Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance
Tim Kendall et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies
Amine Benyamina et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2012)
Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents A Bayesian Meta-Analysis
David Cohen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
David Fraguas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies
Alessandro Zuddas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
Benedetto Vitiello et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Possible induction of mania or hypomania by atypical antipsychotics: An updated review of reported cases
F Rachid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Share Paper
